L-tyrosine and nitric oxide synergize to prevent cytotoxic effects of superoxide.


Autoria(s): Souici A.C.; Fitzhugh A.L.; Keefer L.K.; Felley-Bosco E.
Data(s)

2001

Resumo

We found previously that the nitric oxide donor DEA/NO enhanced lipid peroxidation, DNA fragmentation, and cytotoxicity in human bronchial epithelial cells (BEAS-2B) when they were cultured in LHC-8 medium containing the superoxide-generating system hypoxanthine/xanthine oxidase (HX/XO). We have now discovered that DEA/NO's prooxidant action can be reversed by raising the L-tyrosine concentration from 30 to 400 microM. DEA/NO also protected the cells when they were cultured in Dulbecco's Modified Eagle's Medium (DMEM), whose standard concentration of L-tyrosine is 400 microM. Similar trends were seen with the colon adenoma cell line CaCo-2. Since HPLC analysis of cell-free DMEM or LHC-8 containing 400 microM L-tyrosine, DEA/NO, and HX/XO revealed no evidence of L-tyrosine nitration, our data suggest the existence of an as-yet uncharacterized mechanism by which L-tyrosine can influence the biochemical and toxicological effects of reactive nitrogen species.

Identificador

http://serval.unil.ch/?id=serval:BIB_18500

isbn:0300-483X (Print)

pmid:11522374

doi:10.1016/S0300-483X(01)00428-0

isiid:000170865900009

Idioma(s)

en

Fonte

Toxicology, vol. 165, no. 2-3, pp. 163-170

Palavras-Chave #Bronchi/cytology; Bronchi/drug effects; Caco-2 Cells/drug effects; Cell Line; Cell Survival/drug effects; DNA Damage; Drug Synergism; Humans; Hydrazines/pharmacology; Hydrazines/toxicity; Hypoxanthine/metabolism; Lipid Peroxidation/drug effects; Nitric Oxide/pharmacology; Nitric Oxide/toxicity; Nitric Oxide Donors/pharmacology; Nitric Oxide Donors/toxicity; Nitrogen Oxides; Reactive Oxygen Species/metabolism; Superoxides/antagonists & inhibitors; Superoxides/metabolism; Tyrosine/pharmacology; Xanthine Oxidase/metabolism
Tipo

info:eu-repo/semantics/article

article